Sitagliptin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting ferroptosis
DENG Yu,LAI Kai,LU Zilong,GAO Minglang,LI Ning,GENG Qing
DOI: https://doi.org/10.14188/j.1671-8852.2023.0336
2023-01-01
Abstract:Objective:To investigate the effect and mechanism of sitagliptin(SIT),a dipeptidyl peptidase-4 inhibitor,on lipopolysaccharide(LPS)-induced acute lung injury(ALI).Methods:Male C57BL/6 mice,aged 6-8 weeks,were randomly assigned to four groups:Control,SIT,LPS,and LPS+SIT.An ALI model was established by intraperitoneally injecting LPS(10 mg/kg),and the LPS+SIT group received an intraperitoneal injection of SIT(100 mg/kg)1 hour before the LPS injection.After 12 hours,the mice were sacrificed,and their lung tissues were examined pathologically and molecular-ly.THP-1 cells were cultured and differentiated into a macrophage phenotype.The cells were then randomly divided into five groups:Control,SIT,LPS,LPS+SIT,and LPS+Ferrostatin-1(Fer-1,a ferroptosis inhibitor).SIT(100 mmol/L)and Fer-1(5 pmol/L)were added to the LPS+SIT and LPS+Fer-1 groups,respectively.One hour later,LPS(1 μg/mL)was added to establish a cell inju-ry model,and after 8 hours of LPS stimulation,cells from each group were collected for detection.Results:Compared with the Control group,the lung injury score,lung wet/dry weight ratio,and the levels of inflammatory cytokines IL-1β,IL-6,and TNF-α were significantly increased in the LPS group,while SIT pretreatment significantly alleviated LPS-induced lung tissue injury and inflamma-tion in mice.SIT pretreatment reduced the accumulation of iron and malondialdehyde in lung tissue of mice stimulated by LPS,restored the enzymatic activity of glutathione peroxidase and the expression of nuclear factor erythroid 2-related factor 2(Nrf2),glutathione peroxidase 4(GPX4),solute carrier family 7 member 11(SLC7A11),and heme oxygenase 1(HO-1).In cell experiments,SIT pretreat-ment exerted a similar protective effect as Fer-1,restored the expression of key molecules such as GPX4,which could inhibit ferroptosis,and improved cell viability.Conclusion:SIT pretreatment can significantly ameliorate LPS-induced ALI in mice,which can effectively inhibit LPS-stimulated macrophage ferroptosis,correct iron metabolism and lipid peroxidation disorders,and reduce lung tis-sue injury,thus SIT can serve as a potential therapeutic option for ALI/ARDS.